J J Dlabac-de Lange1, L Bais2, F D van Es1, B G J Visser1, E Reinink3, B Bakker3, E R van den Heuvel4, A Aleman2, H Knegtering1. 1. University of Groningen,University Medical Center Groningen,Department of Psychiatry,Hanzeplein 1,Groningen,The Netherlands. 2. University of Groningen,University Medical Center Groningen,Department of Neuroscience and BCN Neuroimaging Center,Antonius Deusinglaan 2,Groningen,The Netherlands. 3. Lentis Research,Center for Mental Health,Hereweg 80,Groningen,The Netherlands. 4. University of Groningen,University Medical Center Groningen,Department of Epidemiology,Hanzeplein 1,Groningen,The Netherlands.
Abstract
BACKGROUND: Few studies have investigated the efficacy of repetitive transcranial magnetic stimulation (rTMS) treatment for negative symptoms of schizophrenia, reporting inconsistent results. We aimed to investigate whether 10 Hz stimulation of the bilateral dorsolateral prefrontal cortex during 3 weeks enhances treatment effects. METHOD: A multicenter double-blind randomized controlled trial was performed in 32 patients with schizophrenia or schizo-affective disorder, and moderate to severe negative symptoms [Positive and Negative Syndrome Scale (PANSS) negative subscale ⩾15]. Patients were randomized to a 3-week course of active or sham rTMS. Primary outcome was severity of negative symptoms as measured with the Scale for the Assessment of Negative Symptoms (SANS) and the PANSS negative symptom score. Secondary outcome measures included cognition, insight, quality of life and mood. Subjects were followed up at 4 weeks and at 3 months. For analysis of the data a mixed-effects linear model was used. RESULTS: A significant improvement of the SANS in the active group compared with sham up to 3 months follow-up (p = 0.03) was found. The PANSS negative symptom scores did not show a significant change (p = 0.19). Of the cognitive tests, only one showed a significant improvement after rTMS as compared with sham. Finally, a significant change of insight was found with better scores in the treatment group. CONCLUSIONS: Bilateral 10 Hz prefrontal rTMS reduced negative symptoms, as measured with the SANS. More studies are needed to investigate optimal parameters for rTMS, the cognitive effects and the neural basis.
RCT Entities:
BACKGROUND: Few studies have investigated the efficacy of repetitive transcranial magnetic stimulation (rTMS) treatment for negative symptoms of schizophrenia, reporting inconsistent results. We aimed to investigate whether 10 Hz stimulation of the bilateral dorsolateral prefrontal cortex during 3 weeks enhances treatment effects. METHOD: A multicenter double-blind randomized controlled trial was performed in 32 patients with schizophrenia or schizo-affective disorder, and moderate to severe negative symptoms [Positive and Negative Syndrome Scale (PANSS) negative subscale ⩾15]. Patients were randomized to a 3-week course of active or sham rTMS. Primary outcome was severity of negative symptoms as measured with the Scale for the Assessment of Negative Symptoms (SANS) and the PANSS negative symptom score. Secondary outcome measures included cognition, insight, quality of life and mood. Subjects were followed up at 4 weeks and at 3 months. For analysis of the data a mixed-effects linear model was used. RESULTS: A significant improvement of the SANS in the active group compared with sham up to 3 months follow-up (p = 0.03) was found. The PANSS negative symptom scores did not show a significant change (p = 0.19). Of the cognitive tests, only one showed a significant improvement after rTMS as compared with sham. Finally, a significant change of insight was found with better scores in the treatment group. CONCLUSIONS: Bilateral 10 Hz prefrontal rTMS reduced negative symptoms, as measured with the SANS. More studies are needed to investigate optimal parameters for rTMS, the cognitive effects and the neural basis.
Authors: Alkomiet Hasan; Birgit Guse; Joachim Cordes; Wolfgang Wölwer; Georg Winterer; Wolfgang Gaebel; Berthold Langguth; Michael Landgrebe; Peter Eichhammer; Elmar Frank; Göran Hajak; Christian Ohmann; Pablo E Verde; Marcella Rietschel; Raees Ahmed; William G Honer; Berend Malchow; Susanne Karch; Thomas Schneider-Axmann; Peter Falkai; Thomas Wobrock Journal: Schizophr Bull Date: 2015-10-03 Impact factor: 9.306
Authors: Mei Hong Xiu; Heng Yong Guan; Jian Min Zhao; Ke Qiang Wang; Yan Fen Pan; Xiu Ru Su; Yu Hong Wang; Jin Ming Guo; Long Jiang; Hong Yu Liu; Shi Guang Sun; Hao Ran Wu; Han Song Geng; Xiao Wen Liu; Hui Jing Yu; Bao Chun Wei; Xi Po Li; Tammy Trinh; Shu Ping Tan; Xiang Yang Zhang Journal: Schizophr Bull Date: 2020-03-17 Impact factor: 9.306
Authors: Nikolaos Koutsouleris; Thomas Wobrock; Birgit Guse; Berthold Langguth; Michael Landgrebe; Peter Eichhammer; Elmar Frank; Joachim Cordes; Wolfgang Wölwer; Francesco Musso; Georg Winterer; Wolfgang Gaebel; Göran Hajak; Christian Ohmann; Pablo E Verde; Marcella Rietschel; Raees Ahmed; William G Honer; Dominic Dwyer; Farhad Ghaseminejad; Peter Dechent; Berend Malchow; Peter M Kreuzer; Tim B Poeppl; Thomas Schneider-Axmann; Peter Falkai; Alkomiet Hasan Journal: Schizophr Bull Date: 2018-08-20 Impact factor: 9.306